[(2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-(4-{[(4-sulfamoylphenyl)formamido]methyl}-1H-1,2,3-triazol-1-yl)oxan-2-yl]methyl acetate

InChIKey	`RZDXNLXHFKCYHA-WKKMNAASSA-N`
Compound Name	[(2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-(4-{[(4-sulfamoylphenyl)formamido]methyl}-1H-1,2,3-triazol-1-yl)oxan-2-yl]methyl acetate
Canonical SMILES	`CC(=O)OC[C@H]1O[C@@H](n2cc(CNC(=O)c3ccc(S(N)(=O)=O)cc3)nn2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	7.11
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O43570	CA12	Homo sapiens	Human	PF00194	8.4	Ki	ChEMBL;BindingDB
Q9ULX7	CA14	Homo sapiens	Human	PF00194	8.0	Ki	ChEMBL;BindingDB
P00918	CA2	Homo sapiens	Human	PF00194	6.4	Ki	ChEMBL;BindingDB
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	6.4	pIC50	TTD_MultiTarget
Q16790	CA9	Homo sapiens	Human	PF00194	6.4	Ki	ChEMBL;BindingDB